MIA News Archives

Leading researchers point out that a new antidepressant study in NEJM failed to account for withdrawal symptoms, casting doubt on the results.

Study reviews psychological interventions for antidepressant discontinuation.

Greater cumulative doses of drugs that are anticholinergic or block the neurotransmitter acetylcholine are associated with significant increases in dementia and Alzheimer's.

A new article in Lancet Psychiatry debunks past studies claiming that those on low doses of antipsychotics are more likely to relapse.

Meta-analysis of antidepressant tapering finds CBT and MBCT can aid in tapering, but limited studies met inclusion criteria.

Findings point to the role of withdrawal symptoms and prescriber practices in long-term antidepressant use.

Researchers suggest that antidepressant withdrawal can be a possible precipitant of suicide.

Trials of antidepressants for relapse prevention are confounded by withdrawal effects caused by the drugs.

A new review of strategies to support both patients and practitioners through the process of discontinuing antidepressants.

A new article discusses the lack of research dedicated to discontinuing psychiatric drugs and reviews existing strategies.

A new literature review reinforces the need to “down-titrate” or taper antidepressants, especially drugs like Celexa and Paxil.

A new study promotes the use of a standardized approach to antidepressant tapering.

The US Food and Drug Administration is warning the public that the antipsychotic medication ziprasidone "is associated with a rare but serious skin reaction...

Over 70% of schizophrenia patients who are "treatment resistant" have apparently developed dopamine supersensitivity psychosis from long-term use of antipsychotic medications.

Researchers find a lack of current literature on safe, effective ways to manage antidepressant withdrawal and make suggestions for future research.

Researchers review the risks and benefits of deprescribing from antipsychotic drugs and advocate for a patient-centered approach to tapering.

Review study compares outcomes of gradual vs. immediate antipsychotic discontinuation when switching from one drug to another.

The paradox of relieving chronic pain with an antidepressant (and a new set of symptoms).

Study reveals most patients are dissatisfied with prescribers' support when discontinuing antidepressants.

New research examines service user attitudes on discontinuing and reducing antipsychotic drugs.

“Short and simple psychological programs can prevent people from relapsing when they stop their antidepressants.”

A new study investigates how antidepressant withdrawal effects often get confounded with depression relapse in clinical trials.

A new study to be published in the next issue of Schizophrenia Research examines patients suffering from a first-episode of psychosis who stop taking any antipsychotic drugs. The researchers attempt to identify variables that can serve as predictors of the successful discontinuation of antipsychotics. They find, for example, that those who discontinue the drugs have, on average, the same outcomes as those who stay on them, and that those who have better social integration are more likely to discontinue without relapse.

Supportive patient-practitioner relationships are crucial to the successful discontinuation of psychiatric medication.

A new study explores how people manage to discontinue antipsychotic medication and examines how social supports may improve outcomes.